Tazidime In Plastic Container

   
Google
 
Web NewDrugInformation.com

Tazidime In Plastic Container


Drug - Tazidime In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ceftazidime
Multiple ingredients are in alphabetical order.

Strength - 2GM/VIAL
The potency of the active ingredient(s), Ceftazidime. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Tazidime In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062739
The FDA assigned number to Tazidime In Plastic Container. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Tazidime In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 10, 1986
The date Tazidime In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tazidime In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Tazidime In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Tazidime In Plastic Container.

Tazidime In Plastic Container